Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, provided an update on the development of its telehealth platform infrastructure, which is part of its broader digital health strategy for emerging markets. The platform aims to support remote patient engagement, care coordination, and the integration of AI-driven healthcare analytics tools within a technology-enabled healthcare environment.
The telehealth platform is designed to facilitate communication between patients, healthcare providers, and related service participants, while supporting structured data collection and workflow coordination across multiple points of care. The platform is intended to integrate with the Company’s broader AI healthcare platform, including its CardioAI, PulmoAI, and NeuroAI modules, which are being developed to support data-driven analytics and clinical decision-support capabilities. Through this integration, the Company aims to establish a unified digital infrastructure capable of supporting both healthcare services coordination and analytics-driven insights.
Development efforts are currently focused on establishing core platform functionality, including system architecture, data integration, user workflows, and operational processes. The Company is also evaluating approaches to support scalability, interoperability, and integration with existing healthcare systems and technologies. The Company is leveraging its wholly-owned subsidiary in Venezuela to support local platform development, operational coordination, and infrastructure planning. Initial efforts are focused on Venezuela, with potential expansion into other Latin American markets as development progresses.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “We are focused on building a scalable and integrated telehealth platform that can support healthcare coordination and data-driven insights. Our approach is centered on developing infrastructure that can operate within real-world healthcare environments and support future expansion across Latin America.” The Company’s platform is intended to support healthcare providers and related service participants and does not replace licensed medical professionals or clinical decision-making.
The Company continues to advance the development of its digital health and AI platform and evaluate opportunities for expansion across emerging markets. For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. This update highlights the Company’s strategic transition into AI-enabled healthcare and its pursuit of opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination in emerging markets.
